FDA.reportPublic FDA data

liothyronine sodium

Product NDC
51655-641
11-digit product format
516550641
Labeler code
51655
Product ID
51655-641_868fd6e1-2f35-441c-8a23-4d215a486c54
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
liothyronine sodium
Dosage form
TABLET
Route
ORAL
Labeler
Northwind Pharmaceuticals, LLC
Application
ANDA200295
Marketing category
ANDA
Marketing start
2014-11-12
Marketing end
0000-00-00
Substance
LIOTHYRONINE SODIUM
Active strength
25 ug/1
Pharmacologic classes
l-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51655-641-522026-01-07C16284748780-19d75b9d0-92bf-f424-e053-dadaa90a57ce2efef22c-799a-4825-a0a6-7287ef01fdbd
51655-641-522020-01-31C16284748780-19d75b9d0-92bf-f424-e053-dadaa90a57ce2efef22c-799a-4825-a0a6-7287ef01fdbd

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LIOTHYRONINE SODIUMACTIVE INGREDIENTGCA9VV7D2NLIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]1
LIOTHYRONINEACTIVE MOIETY06LU7C9H1VLIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51655-641LIOTHYRONINE SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]1Legacy NDC20141112_2efef22c-799a-4825-a0a6-7287ef01fdbd.zip